U.S. Scientists Deliberately Infected People With Zika—Here’s Why

U.S. Scientists Deliberately Infected People With Zika—Here’s Why

Topline Researchers in the United States have for the first time deliberately infected people with Zika virus, a breakthrough that could help advance our understanding of the disease and accelerate efforts to develop treatments and vaccines. Mosquitoes can carry viruses including dengue, yellow fever, chikungunya and Zika. Copyright 2023 The Associated Press. All rights reserved …

Read more

FDA Approves First RSV Vaccine For Kids—Given To Pregnant Moms—Here’s What To Know

FDA Approves First RSV Vaccine For Kids—Given To Pregnant Moms—Here’s What To Know

Topline The Food and Drug Administration on Monday approved Pfizer’s RSV vaccine to protect infants by vaccinating pregnant parents, becoming the first maternal shot to reach market and offering hope of protecting babies from the ubiquitous and sometimes lethal respiratory infection as shots for adult shots are rolled out for the first time this fall. …

Read more

What is Known about the Rare Covid-19 Vaccine Side Effect, ‘Long Vax Syndrome’?

What is Known about the Rare Covid-19 Vaccine Side Effect, ‘Long Vax Syndrome’?

Postural orthostatic tachycardia syndrome (POTS) has been observed to have a higher risk after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, there have been reports of individuals developing POTS after receiving the Covid-19 vaccine. This phenomenon has been given the name “Long Vax Syndrome” due to the similarity of symptoms to those …

Read more

Promising Trial Results Move First Vaccine for Chikungunya, an Emerging Mosquito-Borne Threat, Closer to Reality

Promising Trial Results Move First Vaccine for Chikungunya, an Emerging Mosquito-Borne Threat, Closer to Reality

Valneva’s vaccine for chikungunya, a mosquito-borne virus that creates symptoms comparable to dengue and Zika, has demonstrated positive results in a late-stage clinical trial according to The Lancet. Valneva used a less potent form of the virus in the vaccine, which was given to 3,082 of the 4,115 healthy adults enrolled in the trial across …

Read more